Clinical Outcomes of Patients with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus (R) Insulin Glargine

Ilag, LL; Costigan, TM; Deeg, MA; Pollom, RK; Chang, CL; Konrad, RJ; Prince, MJ

Ilag, LL (reprint author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.

DIABETES THERAPY, 2017; 8 (3): 545

Abstract

Introduction: We compared insulin antibody response (IAR) profiles in patients with type 1 diabetes (T1D) or type 2 diabetes (T2D) who received LY2963......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索